Amphibole asbestos as an environmental trigger for systemic autoimmune diseases

Area of Science:

• Environmental Health
• Toxicology
• Immunology

Background:

• Systemic autoimmune diseases are increasingly linked to amphibole asbestos exposure.
• Libby Amphibole (LA) in Montana is a primary source of evidence, but studies from Italy and Australia broaden the scope.
• Distinguishing amphibole asbestos from chrysotile is crucial for understanding autoimmune disease risks.

Purpose of the Study:

• To review and summarize current and historical evidence on amphibole asbestos exposure as a risk factor for autoimmune disease.
• To differentiate the effects of amphibole asbestos from chrysotile in driving autoimmune pathologies.
• To address the growing public health concerns regarding environmental asbestos exposure.

Main Methods:

• Review of historical and current scientific literature on amphibole asbestos and autoimmune diseases.
• Analysis of studies differentiating amphibole asbestos from chrysotile exposure.
• Examination of evidence from human and animal (mouse) studies.

Main Results:

• Amphibole asbestos, but not chrysotile, induces antinuclear autoantibodies (ANA) linked to lupus-like conditions.
• Amphibole asbestos exposure drives pathogenic autoantibodies against mesothelial cells.
• These autoantibodies contribute to severe, progressive pleural fibrosis.

Conclusions:

• Amphibole asbestos is a significant risk factor for specific autoimmune diseases and fibrotic lung conditions.
• Unregulated asbestos minerals and widespread environmental occurrences pose increasing public health risks.
• Urgent public and healthcare provider education, screening, and environmental regulations are needed to address rising environmental asbestos exposures.